|
| | Publication Year | Title | Author(s) |
| 21 | Nov-2017 | Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study | Ahn, Myung-Ju; Kim, Dong-Wan; Chul Cho, Byoung; Kim, Sang-We; Lee, Jong Seok; Ahn, Jin-Seok; Kim, Tae Min; Lin, Chia-Chi; Kim, Hye Ryun; John, Thomas ; Kao, Steven; Goldman, Jonathan W; Su, Wu-hou; Natale, Ronald; Rabbie, Sarit; Harrop, Bryony; Overend, Philip; Yang, Zhenfan; Yang, James Chih-Hsin |
| 22 | 12-Aug-2022 | Acute Colonic Pseudo-Obstruction. | Arthur, Thomas; Burgess, Adele N |
| 23 | Jan-2023 | Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass index. | Stewart, Tamasine; Dowling, Mark; Janson, Brett; Siderov, Jim ; Xie, Jing; Grigg, Andrew P ; Khot, Amit |
| 24 | Sep-2023 | Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial. | Huddart, R; Hafeez, S ; Omar, A; Alonzi, R; Birtle, A; Cheung, K C; Choudhury, A; Foroudi, Farshad ; Gribble, H; Henry, A; Hilman, S; Hindson, B; Lewis, R; Muthukumar, D; McLaren, D B; McNair, H; Nikapota, A; Olorunfemi, A; Parikh, O; Philipps, L; Rimmer, Y; Syndikus, I; Tolentino, A; Varughese, M; Vassallo-Bonner, C; Webster, A; Griffin, C; Hall, E |
| 25 | 1-Sep-2016 | The ADAM trial: visiting the road less traveled | Arulananda, Surein; John, Thomas |
| 26 | Feb-2023 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer. | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally; Yeo, Belinda ; Anton, Angelyn; Nottage, Michelle; Wong, Vanessa ; Nott, Louise; Collins, Ian M; Torres, Javier; Barnett, Frances; Lombard, Janine M; Gibbs, Peter; Gately, Lucy |
| 27 | 1-Jul-2006 | Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity. | Mitchell, Paul L R ; Goldstein, David B; Michael, Michael; Beale, Philip; Friedlander, Michael; Zalcberg, John; White, Shane C; Thomson, Jacquelyn A; Clarke, Stephen |
| 28 | 23-Sep-2013 | Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review. | Péron, Julien; Maillet, Denis; Gan, Hui K ; Chen, Eric X; You, Benoit |
| 29 | 31-Jan-2023 | Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. | Herbst, Roy S; Wu, Yi-Long; John, Thomas ; Grohe, Christian; Majem, Margarita; Wang, Jie; Kato, Terufumi; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Yu, Chong-Jen; Vu, Huu Vinh; Lu, Shun; Lee, Kye Young; Mukhametshina, Guzel; Akewanlop, Charuwan; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Urban, Damien; Huang, Xiangning; Bolanos, Ana; Stachowiak, Marta; Tsuboi, Masahiro |
| 30 | Feb-2021 | Adjuvant radiotherapy for endometrial cancer with cervical stromal involvement: A patterns of practice survey in Australia and New Zealand. | Lapuz, Carminia ; Govindarajulu, Geetha; Tacey, Mark A ; Lim, Adeline ; Johnson, Carol |
| 31 | Apr-2018 | Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis. | Tang, Monica; Price, Timothy Jay; Shapiro, Jeremy; Gibbs, Peter; Haller, Daniel G; Arnold, Dirk; Peeters, Marc; Segelov, Eva; Roy, Amitesh; Tebbutt, Niall C ; Pavlakis, Nick; Karapetis, Chris; Burge, Matthew |
| 32 | 2-Nov-2021 | Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice. | Stadtmauer, Edward A; Sullivan, Keith M; El Idrissi, Mohamed; Salaun, Bruno; Alonso Alonso, Aránzazu; Andreadis, Charalambos; Anttila, Veli-Jukka; Bloor, Adrian Jc; Broady, Raewyn; Cellini, Claudia; Cuneo, Antonio; Dagnew, Alemnew F; Di Paolo, Emmanuel; Eom, HyeonSeok; González-Rodríguez, Ana Pilar; Grigg, Andrew ; Guenther, Andreas; Heineman, Thomas C; Jarque, Isidro; Kwak, Jae-Yong; Lucchesi, Alessandro; Oostvogels, Lidia; Polo Zarzuela, Marta; Schuind, Anne E; Shea, Thomas C; Sinisalo, Ulla Marjatta; Vural, Filiz; Yáñez San Segundo, Lucrecia; Zachée, Pierre; Bastidas, Adriana |
| 33 | Oct-2022 | Adoption of respiratory motion management in radiation therapy. | Burton, Alex; Beveridge, Sabeena; Hardcastle, Nicholas; Lye, Jessica ; Sanagou, Masoumeh; Franich, Rick |
| 34 | Aug-2022 | Adult medulloblastoma in an Australian population. | Parakh, Sagun ; Davies, Amy; Westcott, Kerryn; Roos, Daniel; Abou-Hamden, Amal; Ahern, Elizabeth; Lau, Peter K H; Cheruvu, Sowmya; Pranavan, Ganesalingam; Pullar, Andrew; Lynam, James; Gzell, Cecelia; Whittle, James R; Cain, Sarah; Inglis, Po-Ling; Harrup, Rosemary; Anazodo, Antoinette; Hovey, Elizabeth; Cher, Lawrence M ; Gan, Hui K |
| 35 | Jan-2016 | Aggregated adverse-events outcomes in oncology phase III reports: A systematic review. | Maillet, Denis; Gan, Hui K ; Blay, Jean-Yves; You, Benoit; Péron, Julien |
| 36 | 1-Dec-2017 | ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer. | Pietrantonio, Filippo; Di Nicolantonio, Federica; Schrock, Alexa B; Lee, Jeeyun; Tejpar, Sabine; Sartore-Bianchi, Andrea; Hechtman, Jaclyn F; Christiansen, Jason; Novara, Luca; Tebbutt, Niall C ; Fucà, Giovanni; Antoniotti, Carlotta; Kim, Seung Tae; Murphy, Danielle; Berenato, Rosa; Morano, Federica; Sun, James; Min, Bosun; Stephens, Philip J; Chen, Marissa; Lazzari, Luca; Miller, Vincent A; Shoemaker, Robert; Amatu, Alessio; Milione, Massimo; Ross, Jeffrey S; Siena, Salvatore; Bardelli, Alberto; Ali, Siraj M; Falcone, Alfredo; de Braud, Filippo; Cremolini, Chiara |
| 37 | Jul-2018 | Allogeneic stem cell transplantation as a risk factor for recurrent melanoma. | Stevens, Hannah; Raj, Kavita; Ashby, Michael; Grigg, Andrew P |
| 38 | 2-Aug-2021 | Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. | Park, Keunchil; Haura, Eric B; Leighl, Natasha B; Mitchell, Paul L R ; Shu, Catherine A; Girard, Nicolas; Viteri, Santiago; Han, Ji-Youn; Kim, Sang-We; Lee, Chee Khoon; Sabari, Joshua K; Spira, Alexander I; Yang, Tsung-Ying; Kim, Dong-Wan; Lee, Ki Hyeong; Sanborn, Rachel E; Trigo, José; Goto, Koichi; Lee, Jong-Seok; Yang, James Chih-Hsin; Govindan, Ramaswamy; Bauml, Joshua M; Garrido, Pilar; Krebs, Matthew G; Reckamp, Karen L; Xie, John; Curtin, Joshua C; Haddish-Berhane, Nahor; Roshak, Amy; Millington, Dawn; Lorenzini, Patricia; Thayu, Meena; Knoblauch, Roland E; Cho, Byoung Chul |
| 39 | 2018 | An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma. | Wight, Joel C ; Hawkes, Eliza A ; Berlangieri, Salvatore U ; Khor, Richard ; Grigg, Andrew P |
| 40 | 27-Feb-2023 | Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial. | Chmielecki, Juliann; Mok, Tony; Wu, Yi-Long; Han, Ji-Youn; Ahn, Myung-Ju; Ramalingam, Suresh S; John, Thomas ; Okamoto, Isamu; Yang, James Chih-Hsin; Shepherd, Frances A; Bulusu, Krishna C; Laus, Gianluca; Collins, Barbara; Barrett, J Carl; Hartmaier, Ryan J; Papadimitrakopoulou, Vassiliki |
